| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858356 Lactobacillus acidophilus to inhibit cryptosporidiosis in mammals |
| 01/12/1999 | US5858355 Infecting in vitro cultured synovial cells with recombinant viral vector comprising dna sequence encoding interleukin-1 receptor antagonist protein linked to promoter, transplanting cells into arthritic joint space for expression |
| 01/12/1999 | US5858328 Animal model for hepatitis virus infection |
| 01/10/1999 | CA2242648A1 Method of reconstructing animal organs |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/08/1999 | CA2236468A1 Novel use |
| 01/07/1999 | WO1999000511A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 01/07/1999 | WO1999000146A1 Development and use of human pancreatic cell lines |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998039464A3 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 01/07/1999 | WO1998039027A3 Sialyl lewis antigens as targets for immunotherapy |
| 01/07/1999 | EP0888776A1 A product of heat treatment of uronic acid, food, drink or drug including the product |
| 01/07/1999 | EP0888456A2 Prostate specific antigen oligo-epitope peptide |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888118A1 Enhancement of microbial colonisation of the gastrointestinal tract |
| 01/07/1999 | EP0888117A1 Use of arabinogalactan in a sperm wash product |
| 01/07/1999 | EP0784632B1 Process for extracting high-purity von willebrand factor |
| 01/07/1999 | EP0672127B1 Use of thiol redox proteins for reducing disulfide bonds |
| 01/07/1999 | CA2665707A1 Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 01/07/1999 | CA2295315A1 Targeted gene transfer using g protein coupled receptors |
| 01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
| 01/06/1999 | CN1203942A Fresh honey ant liquor |
| 01/06/1999 | CN1203814A Ant medicinal liquor and its preparing method |
| 01/06/1999 | CN1203807A Medicine for curing recurrent stomatocace and Behcet's syndrome |
| 01/06/1999 | CN1203803A Powder for curing ulcerative colitis and proctitis ulcerosa |
| 01/06/1999 | CN1203797A Chinese patent drug for curing cough and asthma |
| 01/06/1999 | CN1203795A Pilose antler-wood frog oil oral liquor and preparing method thereof |
| 01/06/1999 | CN1203794A Freeze-dried sheep placenta extract powder and its production method |
| 01/06/1999 | CN1203793A Artificial tiger-bone and its producing process and use |
| 01/06/1999 | CN1203759A Method for producing snail series drink |
| 01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
| 01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/05/1999 | US5856181 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 01/05/1999 | US5856180 Immortalization of dendritic cells with V-MYC oncogene |
| 01/05/1999 | US5856152 Transgenic supplying to cells |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856120 Method of preparing a biological material for use in ophthalmology |
| 01/05/1999 | US5856091 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
| 01/05/1999 | US5855883 Method of disinsertion of vitreous body from neural retina of the eye with Proteus vulgaris chondroitinases I and II |
| 12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
| 12/30/1998 | WO1998059059A1 Expression system for production of therapeutic proteins |
| 12/30/1998 | WO1998059038A1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 12/30/1998 | WO1998059035A2 Serum-free cell growth medium |
| 12/30/1998 | WO1998058669A2 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 12/30/1998 | WO1998058655A1 Use of a humic acid-containing substance in medicine |
| 12/30/1998 | WO1998044936A3 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
| 12/30/1998 | EP0887418A2 In vivo method of obtaining cell components |
| 12/30/1998 | EP0887410A2 DNA encoding a plasminogen activating protein |
| 12/30/1998 | EP0887098A2 Gas plasma treated porous medium and method of separation using same |
| 12/30/1998 | EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
| 12/30/1998 | EP0887080A2 Use of whey for the specific treatment of beta haemolysing streptococci |
| 12/30/1998 | EP0886679A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 12/30/1998 | EP0886528A1 Use of coxiella bacteria to treat autoimmune disease |
| 12/30/1998 | EP0886522A1 Use of colostrum for the treatment of constipation |
| 12/30/1998 | EP0794823A4 Centrifuge reagent delivery system |
| 12/30/1998 | EP0553244B1 Targeted immunostimulation with bispecific reagents |
| 12/30/1998 | CN2302019Y Wart and mole therapeutical pen |
| 12/30/1998 | CN1203531A Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (GDNF) protein product |
| 12/30/1998 | CN1203099A Shexingkeyu capsule for curing cardiovascular and cerebrovascular disease and preparing process thereof |
| 12/30/1998 | CN1203096A Powder and pellet for strengening Yang |
| 12/30/1998 | CN1203088A Medicinal liquor for treating suppurative bone infection |
| 12/30/1998 | CN1203084A Phospholipid tonic paste |
| 12/30/1998 | CN1203083A Antifissuration skin care cream for feet |
| 12/30/1998 | CN1203041A Formula for health beverage of Chinese wood frog and making technique thereof |
| 12/30/1998 | CN1041384C Medicine for curing liver disease and preparing process thereof |
| 12/30/1998 | CA2594375A1 Bovine adenovirus type 3 genome |
| 12/30/1998 | CA2294195A1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 12/30/1998 | CA2294154A1 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 12/30/1998 | CA2294119A1 Expression system for production of therapeutic proteins |
| 12/29/1998 | US5854403 Method for isolation of highly pure von Willebrand Factor |
| 12/29/1998 | US5854401 Determination of endometrial receptivity toward embryo implantation |
| 12/29/1998 | US5854292 Stimulating the differentiation of preadipocytic cells and therapies based thereon |
| 12/29/1998 | US5854036 Sesquiteterpenic dervatives |
| 12/29/1998 | US5854029 Method for preparing antihypertensive agent |
| 12/29/1998 | US5854010 Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor |
| 12/29/1998 | US5853765 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 12/29/1998 | US5853748 Pharmaceutical compositions |
| 12/29/1998 | US5853747 Therapeutic and dietetic uses of a brain phospholipid-based complex |
| 12/29/1998 | US5853738 Methods for treatment of human immunodeficiency virus infection with pseudomonas phosphoaminolipid extract |
| 12/29/1998 | US5853719 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 12/29/1998 | US5853385 Encapsulated PC12 cell transplants for treatment of Parkinson's disease |
| 12/29/1998 | CA2171281C Immunomodulating compositions from bile |
| 12/29/1998 | CA2064029C Use of mycobacterium vaccae in the prevention of aids |
| 12/29/1998 | CA1340296C Cell growth regulatory factor |
| 12/29/1998 | CA1340295C Human somatomedin carrier protein subunits and process for procucing them |
| 12/27/1998 | CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
| 12/23/1998 | WO1998057672A2 Process for reducing the concentration of viral and molecular pathogens in a biological material |
| 12/23/1998 | WO1998057663A1 Neural transplantation for treating neurological disease |
| 12/23/1998 | WO1998057658A1 Compact epstein-barr virus replicons |
| 12/23/1998 | WO1998057628A1 Composition having capability of removing risk factor during exercise |
| 12/23/1998 | WO1998057555A1 Fermentation products and method for preventing food poisoning |
| 12/23/1998 | EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide |
| 12/23/1998 | EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator |
| 12/23/1998 | EP0885614A2 Method of ex vivo immunizing using heterologous intact bispecific and/or trispecific antibodies |
| 12/23/1998 | EP0885390A1 Affinity labeling libraries and applications thereof |
| 12/23/1998 | EP0885265A1 Mineral pigment microparticles covered with a chitin layer |